Leveraging Existing Models to Support the Discovery of An Emerging Modality

Time: 4:30 pm
day: Conference Day One


• Introducing Prokarium’s work in the field

• Evaluating the available systems and methodologies for testing human-specific drugs in the context of bladder cancer

• Highlighting strategies for effective interaction with CROs to develop bladder cancer models that accurately recapitulate disease characteristics and facilitate immunotherapy studies